UCB Resources

The following UCB resources may be helpful in your search for information about epilepsy, seizures, and treatment.

Web Resources
EpilepsyAdvocate.com
Epilepsy Advocates are a community of people and their families living with all types of epilepsy. Get to know the inspirational stories of Epilepsy Advocates, people like you who are finding ways to take control of their epilepsy and live life on their terms.
http://www.epilepsyadvocate.com

EpilepsyClassroom.com
EpilepsyClassroom.com offers tools and resources that help bring epilepsy into the classroom—so administrators, teachers, parents, and students can help teach other people in their schools about epilepsy.
http://www.epilepsyclassroom.com

The UCB Family Epilepsy Scholarship Program™
The UCB Family Epilepsy Scholarship Program™ provides financial support to encourage academic and personal achievement not just to people with epilepsy, but also to the family members and caregivers who contribute to their successes. UCB, Inc. awards thirty $5,000 scholarships a year, and, since 2005, has awarded over a half million dollars in scholarships.
http://www.epilepsyadvocate.com/resources/scholarship.aspx

Downloadable Materials
Identification and Emergency Card
Patients or their caregivers can fill out this wallet-sized card with their name, address, treatment details, and whom to contact in case of a seizure.
Download an Identification and Emergency Card (PDF 70 KB).

My Health Record
This customized, printable, easy-to-use record captures your medical history, health concerns, and a list of any epilepsy medicines you're taking in one convenient document. Fill yours out and take it to your next neurologist’s appointment.
Download My Health Record (PDF 258 KB)

Other Resources
UCB AED Pregnancy Registry
The UCB AED Pregnancy Registry was established to advance scientific knowledge about safety and outcomes associated with pregnant women being treated with any epilepsy medications from UCB, Inc., including Keppra and Keppra XR®. To ensure broad program access and reach, either your doctor or you can initiate enrollment.

For more information about the UCB AED Pregnancy Registry, talk to your doctor or call 1-888-537-7734 (1-888-KEP-PREG).

“The UCB Family Epilepsy Scholarship Program” is a trademark of the UCB Group of Companies.

Next: External Resources

INDICATIONS

KEPPRA XR (levetiracetam) is a prescription medicine taken by mouth that is used with other medicines to treat partial onset seizures in people 12 years of age and older with epilepsy. KEPPRA XR is available in two dosage strengths: 500mg and 750mg tablets.

KEPPRA (levetiracetam) is a prescription medicine taken by mouth that is used with other medicines to treat primary generalized tonic-clonic seizures in people 6 years of age and older with certain types of generalized epilepsy, myoclonic seizures in people 12 years of age and older with juvenile myoclonic epilepsy, and partial onset seizures in people 1 month of age and older with epilepsy. KEPPRA is available in tablet strengths of 250mg, 500mg, 750mg, and 1000mg, and 100mg of levetiracetam per mL oral solution.

IMPORTANT SAFETY INFORMATION

KEPPRA and KEPPRA XR may not be for everyone. Ask your healthcare provider if KEPPRA or KEPPRA XR is right for you.

Do not take KEPPRA or KEPPRA XR if you are allergic to levetiracetam.

Warnings and Precautions

Antiepileptic drugs, including KEPPRA and KEPPRA XR, may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your healthcare provider right away if you have new or worsening symptoms of depression, any unusual changes in mood or behavior, or suicidal thoughts, behavior, or thoughts about self harm that you have never had before or may be worse than before. KEPPRA and KEPPRA XR may cause extreme sleepiness, tiredness, and weakness, and problems with muscle coordination. You should not drive, operate machinery or do other dangerous activities until you know how KEPPRA or KEPPRA XR affects you. Discontinue KEPPRA or KEPPRA XR and contact your healthcare provider right away if you have allergic reactions such as swelling of the face, lips, eyes, tongue and throat, trouble swallowing or breathing, and hives. Call your healthcare provider right away if you have a skin rash. Serious skin rashes can happen after you start taking KEPPRA and KEPPRA XR. There is no way to tell if a mild rash will become a serious reaction. Do not stop taking KEPPRA or KEPPRA XR unless instructed by your healthcare provider. Stopping a seizure medication all at once can cause seizures that will not stop, a very serious problem.

Common Adverse Reactions

In clinical trials, the most common side effects seen with KEPPRA XR and other formulations of KEPPRA include sleepiness, weakness, dizziness, and infection.

In clinical trials, the most common side effects seen in people who take KEPPRA include sleepiness, weakness, dizziness, and infection. In addition to those previously listed, the most common side effects seen in children who take KEPPRA include tiredness, acting aggressive, nasal congestion, decreased appetite, and irritability.

Talk to your healthcare provider about other possible side effects with KEPPRA or KEPPRA XR. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see additional patient information in the KEPPRA Patient Medication Guide and KEPPRA XR Patient Medication Guide at the end of the full prescribing information. This information does not take the place of talking with your healthcare provider about your condition or your treatment.

The coupon must be accompanied by a valid, signed prescription.

This program is not valid for prescriptions that are reimbursed, in whole or in part, under Medicare (including Medicare Part D), Medicaid, similar federal- or state-funded programs (including any state prescription drug assistance programs and the Government Health Insurance Plan available in Puerto Rico), or where otherwise prohibited by law. Product dispensed pursuant to program rules and federal and state laws. Claims should not be submitted to any public payor (i.e., Medicare, Medicaid, Medigap, Tricare, VA, and DoD) for reimbursement. Patients and pharmacists are responsible for notifying insurance carriers or any other third party who pays for or reimburses any part of the prescription filled using this coupon as may be required by the insurance carrier's terms and conditions and applicable law. The parties reserve the right to amend or end this program at any time without notice. This language may be subject to change in the future.

The coupon may not be reproduced and has no cash value. Offer expires on 12/31/2017.